Cargando…
Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Therapeutic efficacy in COVID-19 is dependent upon disease severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organ...
Autores principales: | Guérin, Philippe J., McLean, Alistair R. D., Rashan, Sumayyah, Lawal, AbdulAzeez, Watson, James A., Strub-Wourgaft, Nathalie, White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021556/ https://www.ncbi.nlm.nih.gov/pubmed/36962738 http://dx.doi.org/10.1371/journal.pgph.0000561 |
Ejemplares similares
-
Correction: Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Publicado: (2023) -
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform
por: Maguire, Brittany J., et al.
Publicado: (2021) -
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
por: Guerin, Philippe J, et al.
Publicado: (2020) -
Guidelines should not pool evidence from uncomplicated and severe COVID-19
por: White, Nicholas J, et al.
Publicado: (2021) -
WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)